Jinhu Ma, Yan Ding, Haifeng Shao, Beiyu Zhang, Chunyu Jiang
{"title":"Two-dimensional speckle-tracking imaging for assessing cardiac dysfunction in liver cirrhosis: correlation with Child-Pugh score.","authors":"Jinhu Ma, Yan Ding, Haifeng Shao, Beiyu Zhang, Chunyu Jiang","doi":"10.1186/s12947-026-00384-4","DOIUrl":"https://doi.org/10.1186/s12947-026-00384-4","url":null,"abstract":"<p><strong>Background: </strong>Although two-dimensional speckle tracking imaging (2D-STI) enables sensitive and quantitative assessment of myocardial deformation, its application in patients with liver cirrhosis (LC) has largely been limited to ventricular function. This study applied 2D-STI to evaluate both ventricular and atrial function in order to identify early myocardial dysfunction in this population.</p><p><strong>Methods: </strong>A total of 82 patients with LC were enrolled and stratified according to the Child-Pugh classification into Class A (n = 30), Class B (n = 29), and Class C (n = 23). Thirty healthy individuals served as controls. All 112 participants underwent conventional echocardiography and 2D-STI assessment.</p><p><strong>Results: </strong>Compared with controls, all LC groups showed reduced left ventricular global longitudinal strain (LVGLS) and right ventricular free wall longitudinal strain (RVFWLS) (both P < 0.05), with a progressive decline from Class A to Class C. In contrast, right ventricular global longitudinal strain (RVGLS) was significantly decreased only in Classes B and C (P < 0.05). Left atrial conduit strain (LAScd) was significantly reduced across all LC groups (P < 0.05), whereas left atrial reservoir strain (LASr) and contractile strain (LASct) demonstrated a biphasic pattern -initially increased, then decreased- compared with controls. Overall, 2D-STI detected cardiac dysfunction earlier than conventional echocardiography. Significant negative correlations were observed between Child-Pugh score and LVGLS, RVFWLS, and RVGLS.</p><p><strong>Conclusion: </strong>Cardiac function is impaired in patients with LC and deteriorates with increasing disease severity. Compared with conventional echocardiography, 2D-STI detects cardiac dysfunction at an earlier stage, providing valuable support for early clinical intervention.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Echocardiography-led multimodal assessment for pulmonary hypertension in a right heart catheterization-referred cohort: incremental value of ECG and natriuretic peptides.","authors":"Yanwei Gao, Wenjie Chen, Jiaqi Ou, Qian Tao, Wei Zhuang","doi":"10.1186/s12947-026-00387-1","DOIUrl":"10.1186/s12947-026-00387-1","url":null,"abstract":"<p><strong>Background: </strong>Right heart catheterization (RHC) is the reference standard for diagnosing pulmonary hypertension (PH), whereas echocardiography is the primary noninvasive tool for identifying patients who require further evaluation. Whether electrocardiography (ECG) and natriuretic peptides provide incremental diagnostic information beyond echocardiographic assessment in patients referred for RHC remains uncertain.</p><p><strong>Methods: </strong>This single-center retrospective study included 130 hospitalized patients with suspected PH who underwent echocardiography, 12-lead ECG, B-type natriuretic peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing, and RHC during the same admission. PH was defined as mean pulmonary arterial pressure > 20 mmHg on RHC. A temporal validation cohort of 42 consecutive eligible patients was used to evaluate the final model without refitting. To reduce collinearity, the final multimodal model included pulmonary artery systolic pressure estimated by echocardiography (PASP ECHO), ECG positivity, and BNP/NT-proBNP positivity. Model discrimination was assessed using receiver operating characteristic analysis, areas under the curve (AUCs) were compared using DeLong's test, calibration was assessed using calibration plots and calibration metrics, and internal validation was performed using bootstrap resampling.</p><p><strong>Results: </strong>Among 130 patients in the derivation cohort, 111 had PH and 19 did not. The final multimodal model showed higher discrimination than PASP ECHO alone in the derivation cohort (AUC 0.825, 95% CI 0.722-0.928 vs. 0.730, 95% CI 0.620-0.841; DeLong P = 0.008). At the Youden threshold, the final model showed high specificity but limited sensitivity, whereas a sensitivity-oriented threshold increased sensitivity at the expense of specificity. Bootstrap internal validation yielded an optimism-corrected AUC of 0.811. In the temporal validation cohort, the final model showed an AUC of 0.792, compared with 0.749 for PASP ECHO alone; this difference was not statistically significant. Bland-Altman analysis showed wide limits of agreement between PASP ECHO and invasive systolic pressure estimates, indicating that echocardiographic and invasive pressure estimates are associated but not interchangeable.</p><p><strong>Conclusions: </strong>In this RHC-referred suspected PH cohort, ECG and natriuretic peptide positivity provided complementary information beyond PASP ECHO. However, because of the small sample size, marked class imbalance, and limited subtype characterization, the proposed multimodal approach should be considered exploratory. Larger prospective studies with subtype stratification and external validation are required before clinical implementation.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yin-Xia Li, Lei Chen, Peng Chen, Yi-Sheng Wang, Rui Shen
{"title":"Ultrasound-based assessment of cardiac and hepatic dysfunction: current status and future directions.","authors":"Yin-Xia Li, Lei Chen, Peng Chen, Yi-Sheng Wang, Rui Shen","doi":"10.1186/s12947-026-00389-z","DOIUrl":"10.1186/s12947-026-00389-z","url":null,"abstract":"<p><p>Heart failure (HF) is a systemic syndrome in which venous congestion and impaired perfusion can produce clinically important hepatic dysfunction. The term cardiohepatic syndrome (CHS) describes this bidirectional interaction, but cardiac and hepatic abnormalities are still often evaluated in parallel rather than as a connected hemodynamic process. Ultrasound is uniquely suited to an integrated assessment because it can characterize cardiac structure and function, systemic venous congestion, hepatic hemodynamics, tissue stiffness, and treatment-related change at the bedside. Conventional transthoracic echocardiography remains the foundation of evaluation, while three-dimensional echocardiography and speckle-tracking techniques improve quantification of right ventricular, atrial, and subclinical myocardial dysfunction. Abdominal Doppler ultrasound, venous congestion scoring, and liver elastography add complementary information, although liver stiffness must be interpreted cautiously because congestion, inflammation, cholestasis, and fibrosis can produce overlapping signals. Artificial intelligence may improve acquisition, measurement reproducibility, and multimodal data integration, but external validation and transparent reporting remain essential. This review summarizes contemporary evidence and proposes a practical, sequential pathway that combines echocardiography, venous Doppler findings, liver stiffness, laboratory biomarkers, and dynamic reassessment after decongestion. The central clinical principle is that CHS should be evaluated as a time-varying cardiohepatic phenotype rather than diagnosed from a single cardiac, hepatic, or biochemical measurement.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13726025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Larissa Bastos, Faris Al-Khalili, Magnus Bäck, Aristomenis Manouras, Johan Engdahl, Kambiz Shahgaldi
{"title":"Echocardiographic markers for left atrial stiffness and left atrial conduction delay in patients with silent paroxysmal atrial fibrillation compared to age-matched controls.","authors":"Larissa Bastos, Faris Al-Khalili, Magnus Bäck, Aristomenis Manouras, Johan Engdahl, Kambiz Shahgaldi","doi":"10.1186/s12947-026-00395-1","DOIUrl":"10.1186/s12947-026-00395-1","url":null,"abstract":"<p><strong>Purpose: </strong>To study left atrial stiffness index (LASI) and left atrial activation time (LA-AT) changes in an older population with silent paroxysmal atrial fibrillation (PAF) compared to age-matched control.</p><p><strong>Methods: </strong>Individuals with newly diagnosed PAF and a randomly selected age-matched control group without AF were enrolled from STROKESTOP2-study. All participants had NT-proBNP levels 125-900 ng/L. TTE examinations were analyzed retrospectively offline using dedicated software. Besides conventional echocardiographic measurements, LA-AT was obtained by measuring the time delay between the onset of the P-wave on ECG and tissue Doppler Á peak wave in lateral LA wall. LASI was calculated as the ratio of left ventricular filling (E/é) to peak atrial longitudinal strain (PALS).</p><p><strong>Results: </strong>Mean age was 76 ± 0.3 years. The PAF group (n = 67) presented significant increase of LASI (0.41 (0.29-0.60) vs. 0.32 (0.29-0.43), P = 0.001) and prolonged LA-AT (170 (140-180) ms vs. 140 (120-144) ms, P < 0.001) compared to controls (n = 94). Subgroup analysis in participants with normal LA volume index (LAVI) ≤ 34 ml/m<sup>2</sup>, LASI and LA-AT remained significantly increased/prolonged in PAF (N = 27) compared to controls (N = 72). NT-proBNP-levels did not differ between PAF (228 (181-348) ng/L) and controls (216 (156-317) ng/L) (P = 0.18). ROC curve analysis identified thresholds LASI > 0.54 and LA-AT > 139 msec for discrimination of silent PAF.</p><p><strong>Conclusion: </strong>Indices reflecting LA stiffness and atrial conduction delay were significantly elevated in recently diagnosed PAF patients. LASI and LA-AT thresholds might non-invasively detect early atrial remodeling without structural enlargement in elderly patients with high risk of PAF and mildly increased NT-proBNP levels.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13721264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149294841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Time-aligned segmental strain as a diagnostic marker for obstructive coronary artery disease in patients with chronic chest pain.","authors":"Assami Rösner, Hatice Akay Caglayan, Mehran Jazbani, Semra Øztemel Sari, Pablo Marti Castellote, Didrik Kjønås, Sandro Queirós","doi":"10.1186/s12947-026-00388-0","DOIUrl":"10.1186/s12947-026-00388-0","url":null,"abstract":"<p><strong>Background: </strong>Myocardial strain curves provide valuable insights into coronary artery disease (CAD) beyond conventional peak strain measurements. This study aimed to evaluate the diagnostic utility of time-aligned segmental strain and strain rate (S/SR) curves to identify obstructive CAD in consecutive chest pain patients.</p><p><strong>Methods: </strong>A total of 510 chest-pain patients referred to coronary computed tomography angiography (CCTA) were included. Segmental strain curves were time-aligned using aortic valve closure (AVC) and cardiac cycle length as reference points. Average S/SR curves were generated for 18 myocardial segments, establishing reference curves from a group of 314 chronic chest-pain patients without CAD (No-CAD). Deviations were defined based on thresholds of peak S/SR or average S/SR curve deviation over systole and the first half of diastole.</p><p><strong>Results: </strong>Significant differences were observed between groups, particularly between the revascularized MI, CABG, or 3-vessel CAD groups compared to the No-CAD group (p<0.05). ROC curve analysis demonstrated excellent diagnostic performance for CABG patients (AUC up to 0.933), while the detection rate for PCI was limited (AUC < 0.7). Global longitudinal strain rate in early diastole (GLSR E) and segmental peak SR E showed the highest diagnostic accuracy. These findings confirm that time-aligned strain analysis improves the detection of significant CAD but remains limited for identifying patients with mild disease.</p><p><strong>Conclusion: </strong>Time-aligned segmental strain analysis improved detection of high-grade disease requiring CABG but could not distinguish single-vessel from non-obstructive CAD. Pathological strain patterns became significant only in advanced CAD, indicating that segmental resting strain analysis has clinical utility primarily for identifying advanced CAD.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13678925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149219692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Discordance between left ventricular ejection fraction and global longitudinal strain during routine cardio-oncology surveillance.","authors":"Jamilah AlRahimi, Amjad Saemaldahar, Rana Madi, Raghad AlJehani, Noof AlKathiri","doi":"10.1186/s12947-026-00386-2","DOIUrl":"https://doi.org/10.1186/s12947-026-00386-2","url":null,"abstract":"<p><strong>Background: </strong>Left ventricular ejection fraction (EF) and global longitudinal strain (GLS) are widely used for cardiac surveillance in patients receiving potentially cardiotoxic cancer therapy. While GLS is more sensitive for detecting early myocardial dysfunction, the relationship between EF and GLS in routine clinical practice remains incompletely characterized, and discordance between these parameters may complicate clinical interpretation.</p><p><strong>Methods: </strong>This retrospective observational study included 117 oncology patients undergoing serial echocardiographic assessment at baseline, early follow-up (6-12 weeks), and short-term follow-up (3-6 months). EF was measured by biplane Simpson's method, and GLS by speckle-tracking echocardiography as absolute values. EF deterioration was defined as a ≥ 10% absolute reduction or EF < 53%, while GLS deterioration was defined as a ≥ 15% relative reduction in absolute GLS magnitude. Concordance between EF and GLS deterioration was assessed, using Cohen's kappa and McNemar's test.</p><p><strong>Results: </strong>Mean EF and GLS values remained stable (EF p = 0.124; GLS p = 0.803). EF deterioration occurred in 32 patients (27.4%), and GLS deterioration in 25 patients (21.4%). Discordance was common, with isolated GLS deterioration in 17 patients (14.5%), and EF deterioration without GLS decline in 24 patients (20.5%), representing discordance in 41% of patients. Agreement was poor (κ = 0.05), and McNemar's test was not significant (p = 0.27). ΔGLS showed a weak association with ΔEF (r = 0.19, p = 0.036).</p><p><strong>Conclusions: </strong>Although systolic function remained stable overall, clinically relevant deterioration occurred in a subset. Frequent EF-GLS discordance highlights their complementary but non-interchangeable roles in cardio-oncology surveillance.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13637118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Assessing the left atrial function via echocardiography to detect cirrhotic cardiomyopathy in patients with liver cirrhosis - a scoping review.","authors":"M Swathi Poojary, Shiran Shetty, Jyothi Samanth, Mahidhar Jeedigunta, Vennila Jaganathan, Shubha Srinivas, Monika P Jawanjal, Sridevi Prabhu, Vidya Nayak, Krishnananda Nayak","doi":"10.1186/s12947-026-00383-5","DOIUrl":"https://doi.org/10.1186/s12947-026-00383-5","url":null,"abstract":"<p><strong>Background: </strong>Cirrhotic cardiomyopathy (CCM) is a condition observed in patients with chronic liver disease, characterized by dysfunction in both cardiac diastolic and/or systolic function. This condition is often underdiagnosed due to a lack of awareness and the possibility of misdiagnosis. Consequently, there is limited data regarding subclinical CCM in individuals with end-stage liver disease. Furthermore, there is currently no established cardiac biomarker to assess cardiovascular risk and outcomes in patients with liver cirrhosis. To address this issue, we conducted a scoping review to map the existing evidence and identify research gaps in echocardiographic assessment of left atrial (LA) function for detecting CCM in patients with liver cirrhosis.</p><p><strong>Methods: </strong>We systematically searched the Scopus, PubMed, and Web of Science databases using Population, Concept, and Context framework. The population is adult patients with liver cirrhosis. The concept is to assess LA function via echocardiography. Context is to detect CCM.</p><p><strong>Results: </strong>We identified 364 articles, of which 24 were eligible for full-text review. Ultimately, 20 articles were included in the final analysis. Our dataset revealed various cardiovascular manifestations involving LA. Key findings related to CCM included LA enlargement and increased LA diameter and volume, which correlated with the Child-Turcotte-Pugh and Model for End-Stage Liver Disease scores. Additionally, we observed a reduction in LA strain. LA diameter, volume, and LA strain were associated with outcome prediction.</p><p><strong>Conclusion: </strong>Evaluating LA function with advanced echocardiographic techniques offers a promising approach for early detection and prognostic assessment of CCM. To translate these findings into standardized clinical practice, bridging existing evidence gaps with well-designed studies is crucial.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13628834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaofang Zhong, Shuyu Luo, Lixin Chen, Yingying Liu
{"title":"A balloon-like cardiac myxoma mimicking a blood-filled cyst.","authors":"Xiaofang Zhong, Shuyu Luo, Lixin Chen, Yingying Liu","doi":"10.1186/s12947-026-00376-4","DOIUrl":"10.1186/s12947-026-00376-4","url":null,"abstract":"<p><strong>Background: </strong>Myxoma is the most common benign cardiac tumor. We reported a rare variant of balloon-like cystic cardiac myxoma.</p><p><strong>Case presentation: </strong>A 54-year-old woman presented with exertional dyspnea, chest tightness, and intermittent dizziness. Electrocardiogram and laboratory studies were unremarkable. Transthoracic echocardiography(TTE) revealed a balloon-like cystic mass in the left atrium mimicking a blood-filled cyst. Contrast echocardiography demonstrated a contrast-filled lesion with iso-myocardial enhancement. Transesophageal echocardiography(TEE) identified a distinct arterial inflow at the cyst base and an outflow orifice, which was further confirmed during surgery by the administration of cardioplegic solution. The mass was successfully resected and confirmed a cystic cardiac myxoma.</p><p><strong>Discussions: </strong>Cystic myxoma is a rare variant with only few cases reported. The presented balloon-like variant of myxoma exhibited unique anatomical and hemodynamic features that elucidate its formation mechanism.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13591671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149012147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eluisa La Franca, Francesca Parisi, Alessandro Lucchino, Leyla Elif Sade, Tim Wong, Italia Loddo, Luigi Alioto, Giovanni Gentile, Michele Pilato, Manlio Cipriani, Francesco Fulvio Faletra
{"title":"Hypertrophic cardiomyopathy: state of the art on diagnosis and current therapeutic approach.","authors":"Eluisa La Franca, Francesca Parisi, Alessandro Lucchino, Leyla Elif Sade, Tim Wong, Italia Loddo, Luigi Alioto, Giovanni Gentile, Michele Pilato, Manlio Cipriani, Francesco Fulvio Faletra","doi":"10.1186/s12947-026-00382-6","DOIUrl":"10.1186/s12947-026-00382-6","url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic cardiomyopathy is the most common genetic cardiomyopathy and is characterized by unexplained myocardial hypertrophy. This condition exhibits marked clinical and prognostic heterogeneity. Advances in cardiovascular imaging techniques and genetic testing have significantly improved the diagnostic accuracy, phenotypic characterization, and prognostic assessment. Hypertrophic cardiomyopathy can present with a broad spectrum of genetic substrates and clinical presentations, ranging from asymptomatic individuals to those with heart failure, arrhythmias, and even sudden cardiac death. The first-line method for diagnosis, risk stratification, and follow-up of these patients is echocardiography, but additional techniques, such as cardiac magnetic resonance imaging, provide complementary information, such as quantification of fibrosis, and more accurate measurements. Genetic testing contributes to etiological diagnosis and family screening. Treatment options include both pharmacological therapy (such as beta-blockers, calcium channel blockers, and disopyramide), which is the first-line therapy, and septal reduction techniques (alcohol septal ablation, surgical myectomy), which should be reserved for selected patients. Recently, cardiac myosin inhibitors have emerged as a novel therapeutic option, demonstrating significant reductions in left ventricular outflow tract obstruction and improvement in symptoms.</p><p><strong>Conclusion: </strong>Hypertrophic cardiomyopathy has evolved considerably with advances in imaging techniques, genetic evaluation, and targeted therapies. This review examines the primary diagnostic and management strategies, both established and emerging, for hypertrophic cardiomyopathy.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148963172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Moderate aortic stenosis: diagnostic pitfalls and the role of multimodality imaging in risk stratification and clinical management.","authors":"Gloria Santangelo, Alessandro Maloberti, Chiara Tognola, Massimiliano Monticelli, Claudio Montalto, Andrea Barbieri, Antonella Moreo, Cristina Giannattasio, Stefano Carugo, Pompilio Faggiano","doi":"10.1186/s12947-026-00381-7","DOIUrl":"10.1186/s12947-026-00381-7","url":null,"abstract":"<p><strong>Background: </strong>Moderate aortic stenosis (AS) has traditionally been considered a transitional and relatively benign stage of valvular disease. Yet, contemporary evidence shows that it is associated with substantial morbidity and mortality even before progression to severe AS. This paper synthesizes current evidence on the limitations of standard echocardiography, highlights the role of advanced imaging and artificial intelligence, and outlines evolving strategies for risk stratification and clinical management. Multimodality imaging provides a more accurate assessment of disease severity beyond conventional echocardiographic parameters: computed tomography aortic valve calcium scoring, cardiac magnetic resonance, and 18 F-sodium fluoride positron emission tomography reveal early myocardial injury and identify rapid progressors. AI further enhances reproducibility and supports the development of emerging prognostic models. A staging approach that integrates ventricular, atrial, and right-sided involvement correlates more closely with clinical outcomes than valve metrics alone, enabling a more comprehensive characterization of disease burden. Although guideline-directed surveillance remains the standard strategy for most patients, selected high-risk individuals, particularly those with adverse remodeling, elevated biomarkers, or recurrent heart failure admissions, may benefit from earlier intervention.</p><p><strong>Short conclusion: </strong>While waiting for the results of ongoing randomized trials cardiologist should implement all the imaging multimodality tools available in order to individuate patients in which an earlier treatment of moderate AS will more probably improve long-term outcomes.</p>","PeriodicalId":9613,"journal":{"name":"Cardiovascular Ultrasound","volume":"24 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148900201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}